Viking Therapeutics, Inc. - COM (VKTX)

Historical Portfolio Holders from Q2 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
81.5M
Holdings value Q3 2024
$5.16B
Value change Q3 2024
+$151M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
413
Number of buys Q3 2024
261
Number of sells Q3 2024
-155
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 81.5M $5.16B +$151M $63.31 425
2024 Q2 80.3M $4.26B -$165M $53.01 389
2024 Q1 79.8M $6.54B +$360M $82.00 371
2023 Q4 76.3M $1.42B +$16.9M $18.61 196
2023 Q3 77.1M $853M +$8.95M $11.07 181
2023 Q2 74.8M $1.21B +$127M $16.21 196
2023 Q1 66.5M $1.11B +$548M $16.65 184
2022 Q4 34M $320M +$76.4M $9.40 129
2022 Q3 26.6M $72.3M -$1.01M $2.72 95
2022 Q2 26.7M $77.2M -$11.6M $2.89 98
2022 Q1 31M $93.2M -$16.6M $3.00 132
2021 Q4 36.2M $166M -$8.9M $4.60 133
2021 Q3 37.8M $238M -$338K $6.28 125
2021 Q2 37.9M $227M -$19.6M $5.99 135
2021 Q1 41M $259M +$21M $6.32 139
2020 Q4 37.7M $213M -$11.1M $5.63 138
2020 Q3 39.6M $230M -$4.36M $5.82 142
2020 Q2 40.2M $290M +$8.15M $7.21 137
2020 Q1 39.4M $184M -$8.37M $4.68 133
2019 Q4 39.8M $319M -$5.27M $8.02 138
2019 Q3 40.7M $280M -$33.4M $6.88 141
2019 Q2 45.1M $374M -$7.34M $8.30 152
2019 Q1 45.7M $454M -$4.97M $9.94 161
2018 Q4 46.9M $359M -$11.2M $7.65 160
2018 Q3 43.2M $753M +$281M $17.42 150
2018 Q2 31.6M $300M +$126M $9.49 117
2018 Q1 20.9M $91.4M +$50.6M $4.37 62
2017 Q4 9.33M $37.9M +$30.1M $4.06 32
2017 Q3 2.02M $3.85M +$1.49M $1.91 17
2017 Q2 1.57M $1.69M +$856K $1.08 10
2017 Q1 770K $1.12M +$227K $1.46 10
2016 Q4 635K $756K -$869K $1.19 10
2016 Q3 1.21M $1.7M +$496K $1.41 12
2016 Q2 860K $1.08M +$1.03M $1.26 12
2016 Q1 44.4K $65K -$26K $1.53 6
2015 Q4 41.3K $140K -$14.6K $3.36 5
2015 Q3 43.2K $252K -$77.6K $5.83 6
2015 Q2 54K $384K +$384K $7.10 5